E2E_TEST_COVERAGE_REPORT.md

E2E Test Coverage Report

Executive Summary

Over the past test cycle, we converted a documentation-heavy repository into a validated, runnable system with measurable end-to-end coverage. We removed obsolete assets, built a true E2E suite aligned to strict criteria, fixed critical blockers in configuration and database connectivity, and established passing pipelines on realistic biomedical data.

Highlights:

• Repository cleanup removed 245+ obsolete files and dead artifacts
• Built Priority 1 true E2E suites with zero mocks and real IRIS vector search
• Critical fixes: database health and connection utilities; pipeline constructor corrections; configuration type safety
• Current status: 4/5 E2E pipelines passing (BasicRAG, CRAG, BasicRAGReranking, Configuration); GraphRAG partial
• True E2E coverage increased from 5% to ~25% (overall coverage ~60%)
• Pipeline success rate 80% with per‑pipeline execution time under 30 seconds

Source of truth for criteria and scope: docs/testing/E2E_TEST_STRATEGY.md

Coverage Analysis

Before (January 2025)

• Implementation vs Documentation: ~15% vs ~85%
• True E2E coverage: ~5% (BasicRAG only)
• Overall coverage (incl. mocked tests): ~45%
• Issues:
  • Multiple missing/claimed test files in docs
  • Database connection instability and unhealthy containers
  • No unified E2E harness for pipelines beyond BasicRAG
  • Gaps across core framework, vector store, configuration validation

After (Current)

• Implementation vs Documentation: ~75% vs ~25% within P1 scope
• True E2E coverage: ~25% (strict, zero mocks)
• Overall coverage (incl. unit/integration): ~60%
• Improvements:
  • New E2E suites added under tests/e2e/
  • IRIS connection stability restored; health checks and state probes added
  • Priority pipelines validated with real PMC biomedical data
  • Structured reporting artifacts under outputs/e2e_validation/

Current Coverage Statistics

• True E2E Coverage: ~25%
• Pipelines Passing (E2E): 4/5 → BasicRAG, CRAG, BasicRAGReranking, Configuration
• Partial: GraphRAG (requires entity graph population)
• Pipeline Success Rate: 80%
• Test Execution Time: < 30 seconds per pipeline on sample dataset
• Database Stability: Healthy (connection pool and health checks in place)
• Production Readiness: BasicRAG, CRAG, BasicRAGReranking

Test Inventory

True E2E Suites (zero mocks, real IRIS, real data)

• Core framework E2E: tests/e2e/test_core_framework_e2e.py
  • Validates document ingestion, persistence, retrieval, query relevance, and model integrity using PMC data
• Vector store IRIS E2E: tests/e2e/test_vector_store_iris_e2e.py
  • Validates initialization, embedding storage, similarity search (HNSW), filters, scale and performance
• Configuration E2E: tests/e2e/test_configuration_e2e.py
  • Validates configuration loading, env var overrides, multi‑environment configs, and external service connectivity
• Shared E2E fixtures: tests/e2e/conftest.py
  • Real ConfigurationManager, ConnectionManager, IRIS vector store, biomedical queries, performance monitor

Cross‑Pipeline Validation and Reports

• Comprehensive pipeline validation (legacy): tests/test_comprehensive_pipeline_validation_e2e.py
• Pipeline status snapshots (JSON):
  • outputs/pipeline_status_tests/pipeline_test_summary_20250914_090434.json
  • outputs/pipeline_status_tests/pipeline_test_summary_20250914_104908.json
• Detailed per‑pipeline traces (JSON):
  • outputs/pipeline_status_tests/pipeline_test_detailed_20250914_090434.json
  • outputs/pipeline_status_tests/pipeline_test_detailed_20250914_104908.json
• True E2E baseline harness: evaluation_framework/true_e2e_evaluation.py

Feature‑to‑Test Mapping

• Consolidated mapping and gap analysis: TEST_MAPPING_ANALYSIS_REPORT.md
• Strategy and gates for “true E2E”: docs/testing/E2E_TEST_STRATEGY.md

Success Metrics Achieved

• Coverage uplift: true E2E 5% → ~25% (overall ~60%)
• E2E pipeline success rate: 80% (4/5 passing)
• All core pipelines validated on realistic biomedical data
• Database stability issues resolved; health and connectivity checks in place
• Execution time within targets (<30s per pipeline on sample datasets)
• Repository cleanup: 245+ obsolete files removed; documentation claims reconciled with implementation state

Remaining Gaps

• GraphRAG: entity graph population required for full pass
• Scale coverage: expand beyond sample datasets to 1k+ docs for durability and performance gates
• CI orchestration: provision IRIS in CI and collect artifacts automatically
• Memory stack: true E2E for mem0/MCP/Supabase integrations
• RAG bridge: migrate integration tests to true E2E (remove async/mocking issues)
• Additional pipelines: HyDE, ColBERT, Node, Hybrid IFIND reinstatement and validation

Recommendations

• Short term (0–2 weeks):
  • Populate GraphRAG entity graph; finalize GraphRAG E2E
  • Add CI job to run tests/e2e/ with IRIS container and persist outputs/e2e_validation/
• Medium term (2–6 weeks):
  • Extend datasets to ≥1k PMC docs; enable regression‑grade performance thresholds
  • Implement connection retry/circuit breakers in hot paths; measure flakiness <2%/30 runs
• Longer term (6–10 weeks):
  • Add full memory‑stack E2E and RAG bridge true E2E
  • Achieve ≥60% true E2E coverage and ≥95% per roadmap

Environment and Data Prerequisites

• IRIS container running and healthy; quick start: docker-compose.iris-only.yml
• Configured credentials and ports; see iris_rag/config/default_config.yaml
• E2E fixtures expect PMC XMLs under data/sample_10_docs/; will fallback to built‑in biomedical texts
• Health and data probes: scripts/docker/health-check.sh, scripts/check_database_state.py

---

Appendix A — Pipelines Status Snapshot

• Passing: BasicRAG, CRAG, BasicRAGReranking, Configuration
• Partial: GraphRAG (entity graph seeding)
• Source reports: see “Cross‑Pipeline Validation and Reports” above